Clinical-biological characteristics and treatment outcomes of pediatric pro-B ALL patients enrolled in BCH-2003 and CCLG-2008 protocol: a study of 121 Chinese children

Clinical-biological characteristics and treatment outcomes of pediatric pro-B ALL patients enrolled in BCH-2003 and CCLG-2008 protocol: a study of 121 Chinese children

Abstract Background Although leukemic blast cells of Pro-B cell acute lymphoblastic leukemia (ALL) are arrested at the same stage of B cell differentiation, the immature B cell subtype is still biologically heterogeneous and is associated with diverse outcomes. This study aimed to explore the clinic...

Full description

Bibliographic Details
Main Authors: Chao Gao, Shu-Guang Liu, Zhi-Xia Yue, Yi Liu, Jing Liang, Jun Li, Yuan-Yuan Zhang, Jiao-Le Yu, Ying Wu, Wei Lin, Hu-Yong Zheng, Rui-Dong Zhang
Format: Article
Language:English
Published: BMC 2019-11-01
Series:Cancer Cell International
Subjects:
Pro-B cell
Pediatric
Acute lymphoblastic leukemia
Biological characteristics
Prognostic factor
Online Access:http://link.springer.com/article/10.1186/s12935-019-1013-9

Internet

http://link.springer.com/article/10.1186/s12935-019-1013-9

Similar Items